From Name:
From Email:
To Name:
To Email:

Optional Message:

Can This Pharma Go From Good To Great?

from Motley Fool

Actavis PLC's stock just keeps climbing. Over the past two years, the share price has jumped by an astounding 230 percent. Even before its recent acquisition of Allergan, which, at $66 billion, was the biggest healthcare deal in six years, the generic-drug company has transformed itself from a small fish in a crowded pond into a major pharmaceutical contender. Looking back almost five years, when Actavis was called Watson Pharmaceuticals, the company has streaked up more than 625 percent. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063